Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Both Swiss companies, Debiotech SA and Valtronic SA, announced today that they have entered into an exclusive partnership agreement regarding the manufacturing of the electronic Controller unit for Debiotech's novel insulin "JewelPUMPTM".
Representing the most advanced use of microfluidic MEMS (Micro-Electro-Mechanical Systems) technology in diabetes treatment, the watertight pump can be mounted on a disposable skin patch to provide continuous insulin infusion and is controlled by a dedicated smartphone device incorporating a BGM (blood-glucose meter), thus enabling substantial improvements in the treatment efficiency and the quality of life of diabetic patients.
The highly miniaturized disposable insulin pump combines Debiotech's expertise in insulin delivery systems with Valtronic's experience in manufacturing high-quality and ultra-miniaturized electronic devices.
http://www.azonano.com/news.aspx?newsID=26675
Representing the most advanced use of microfluidic MEMS (Micro-Electro-Mechanical Systems) technology in diabetes treatment, the watertight pump can be mounted on a disposable skin patch to provide continuous insulin infusion and is controlled by a dedicated smartphone device incorporating a BGM (blood-glucose meter), thus enabling substantial improvements in the treatment efficiency and the quality of life of diabetic patients.
The highly miniaturized disposable insulin pump combines Debiotech's expertise in insulin delivery systems with Valtronic's experience in manufacturing high-quality and ultra-miniaturized electronic devices.
http://www.azonano.com/news.aspx?newsID=26675